On June 12, 2025, InMed Pharmaceuticals Inc. announced the resignation of its auditor, Marcum LLP, which will take effect on the same day, and the acceptance of CBIZ CPAs P.C. as the new auditor. Additionally, a shareholder meeting on June 13, 2025, failed to meet quorum requirements for a proposal regarding the issuance of shares, despite 60% support from those present.